Grattan Institute ‘misses the point’ on pricing: Medicines Australia

The Grattan Institute’s latest report misses the point on medicines pricing, says Medicines Australia. Enduring reforms to the PBS polices are achieving substantial savings for government and the Australian medicines industry is on the cusp of yet another: the biggest reform since 2007, the group says. “Measures currently before the Parliament will generate as much